CATALOGO DEI PRODOTTI DELLA RICERCA

Ferrarini, Isacco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 731
NA - Nord America 680
AS - Asia 439
AF - Africa 17
SA - Sud America 9
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.882
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 672
CN - Cina 228
SG - Singapore 149
GB - Regno Unito 145
IT - Italia 131
RU - Federazione Russa 98
IE - Irlanda 83
SE - Svezia 80
FR - Francia 77
DE - Germania 49
FI - Finlandia 29
VN - Vietnam 19
ID - Indonesia 16
TG - Togo 10
UA - Ucraina 10
CA - Canada 8
ES - Italia 7
KR - Corea 7
SC - Seychelles 6
AT - Austria 5
AU - Australia 5
CL - Cile 5
NL - Olanda 5
HK - Hong Kong 4
IN - India 4
PT - Portogallo 4
TR - Turchia 4
JP - Giappone 3
CH - Svizzera 2
DK - Danimarca 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BR - Brasile 1
CO - Colombia 1
CZ - Repubblica Ceca 1
FK - Isole Falkland (Malvinas) 1
GE - Georgia 1
IR - Iran 1
JO - Giordania 1
KW - Kuwait 1
MA - Marocco 1
PE - Perù 1
PL - Polonia 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 1.882
Salva come PNG Salva come JPEG
Città #
Chandler 165
Southend 133
Singapore 129
Dublin 78
Beijing 59
Ashburn 43
Jacksonville 42
Verona 31
Lawrence 28
Princeton 28
Woodbridge 26
Helsinki 24
Jinan 20
Wilmington 19
Nanjing 16
Ann Arbor 15
Jakarta 15
Redmond 15
Shenyang 13
Sindelfingen 13
Houston 12
Seattle 12
Zhengzhou 11
Lomé 10
Milan 10
Dong Ket 9
Fairfield 9
Hebei 8
Santa Clara 8
Bologna 7
New York 7
Seoul 7
Tianjin 7
Changsha 6
Columbus 6
Dallas 6
Mahé 6
Redwood City 6
Toronto 6
Trento 6
Washington 6
Barcelona 5
Guangzhou 5
Haikou 5
Hangzhou 5
Nanchang 5
Vienna 5
Arezzo 4
Boardman 4
Cagliari 4
Hong Kong 4
Jiaxing 4
Kent 4
Lanzhou 4
Leawood 4
Montichiari 4
Moscow 4
Taizhou 4
Amsterdam 3
Buffalo 3
Dearborn 3
Lisbon 3
Los Angeles 3
Melbourne 3
Ningbo 3
Norwalk 3
San Francisco 3
Shenzhen 3
Tokyo 3
Abbadia San Salvatore 2
Aberdeen 2
Ansbach 2
Atlanta 2
Bari 2
Cambridge 2
Canberra 2
Chicago 2
Falkenstein 2
Florence 2
Frankfurt am Main 2
Fuzhou 2
Gunzenhausen 2
Mehlingen 2
Newark 2
Providence 2
Saint Louis 2
San Martino di Lupari 2
Vergiate 2
Zurich 2
Amman 1
Andover 1
Aurora 1
Bogotá 1
Bratislava 1
Brierley Hill 1
Canary Wharf 1
Castelfranco Veneto 1
Chieti 1
Clifton 1
Copenhagen 1
Totale 1.235
Salva come PNG Salva come JPEG
Nome #
CXCL12 and [N33A]CXCL12 in 5637 and HeLa Cells: Regulating HER1 Phosphorylation via Calmodulin/Calcineurin 111
Chronic graft versus host disease is associated with erectile dysfunction in allogeneic hematopoietic stem cell transplant patients: a single-center experience 101
Immunologic evidence of a strong association between non-Hodgkin lymphoma and simian virus 40 91
Erectile Dysfunction after Allogeneic Hematopoietic Stem Cell Transplant: Results from a Single Center Experience 91
Activation of Protein Tyrosine Phosphatase Receptor Type γ Suppresses Mechanisms of Adhesion and Survival in Chronic Lymphocytic Leukemia Cells 79
Synthetic PGI-2 (Iloprost) treatment in patients with resistant sclerodermic chronic GVHD (cGVHD) after Allogeneic Hematopoietic Stem Cell Transplantation 73
IMMUNE THROMBOCYTOPENIA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: CASE REPORT AND BRIEF OVERVIEW OF TREATMENT STRATEGIES 72
CXCR4- and BCR-triggered integrin activation in B-cell chronic lymphocytic leukemia cells depends on JAK2-activated Bruton's tyrosine kinase 71
High prevalence of antibodies reacting to mimotopes of Simian virus 40 large T antigen, the oncoprotein, in serum samples of patients affected by non-Hodgkin lymphoma 68
BID and the α-bisabolol-triggered cell death program: converging on mitochondria and lysosomes 66
West Nile Virus Encephalitis in Haematological Setting: Report of Two Cases and a Brief Review of the Literature 65
Monocyte-to-macrophage switch reversibly impaired by Ibrutinib. 65
Evans syndrome secondary to chronic lymphocytic leukaemia: presentation, treatment, and outcome 61
Classical Hodgkin lymphoma cells may promote an IL-17-enriched microenvironment 61
Efficient lysis of B-chronic lymphocytic leukemia cells by the plant-derived sesquiterpene alcohol α-bisabolol, a dual proapoptotic and antiautophagic agent 60
Oncogenic Mutations of MYD88 and CD79B in Diffuse Large B-Cell Lymphoma and Implications for Clinical Practice 59
ONC212 IS A NOVEL MITOCAN ACTING SYNERGISTICALLY WITH GLYCOLYSIS INHIBITION IN PANCREATIC CANCER 54
Clinical Characteristics and Outcome of West Nile Virus Infection in Patients with Lymphoid Neoplasms: An Italian Multicentre Study 52
ONC201 and imipridones: Anti-cancer compounds with clinical efficacy. 52
COVID-19 (SARS-CoV-2 infection) in lymphoma patients: A review 50
The mitochondrial anti-apoptotic dependencies of hematologic malignancies: from disease biology to advances in precision medicine 49
A single amino acid substitution in CXCL12 confers functional selectivity at the beta-arrestin level 48
Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study 48
The Evolving Knowledge on T and NK Cells in Classic Hodgkin Lymphoma: Insights into Novel Subsets Populating the Immune Microenvironment 40
B-cell receptor signaling activity identifies patients with mantle cell lymphoma at higher risk of progression 37
ONC212 is a Novel Mitocan Acting Synergistically with Glycolysis Inhibition in Pancreatic Cancer 34
SARS-CoV-2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID-19 cohort 22
Real-world Outcomes of Relapsed/Refractory Diffuse Large B-cell Lymphoma Treated With Polatuzumab Vedotin-based Therapy 21
Two Distinct Clinical Patterns of Ibrutinib-to-Venetoclax Transition in Relapsed Chronic Lymphocytic Leukemia Patients 21
Outcomes of younger patients with mantle cell lymphoma experiencing late relapse (>24 months): the LATE-POD study 20
How COVID-19 pandemic changed our attitude to venetoclax-based treatment in chronic lymphocytic leukemia 20
Long-term remissions with Gilteritinib in early relapse after allogeneic stem cell transplantation of FLT3/NPM1 mutated acute myeloid leukemia 20
An updated portrait of monocyte-macrophages in classical Hodgkin lymphoma 19
Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia 19
Rituximab and Bendamustine (BR) Compared with Rituximab, Bendamustine, and Cytarabine (R-BAC) in Previously Untreated Elderly Patients with Mantle Cell Lymphoma 18
Efficacy of R-COMP in comparison to R-CHOP in patients with DLBCL: A systematic review and single-arm metanalysis 17
Targeting CD19 in diffuse large B-cell lymphoma: An expert opinion paper 17
Decreased apoptotic priming and loss of BCL-2 dependence are functional hallmarks of Richter's syndrome 16
Case Report: Rapid renal response to venetoclax monotherapy in a CLL patient with secondary membranous glomerulonephritis 13
Extracellular Vesicles based STAT3 delivery as innovative therapeutic approach to restore STAT3 signaling deficiency 13
Monocyte-to-platelets ratio (MPR) at diagnosis is associated with inferior progression-free survival in patients with mantle cell lymphoma: a multi-center real-life survey 13
Successful rechallenge with azacytidine and venetoclax after sustained treatment-free remission in a relapsed acute myeloid leukemia patient: a case report 9
CAT rs1001179 Single Nucleotide Polymorphism Identifies an Aggressive Clinical Behavior in Chronic Lymphocytic Leukemia 6
A brisk peripheral T-cell reaction following rituximab treatment for follicular lymphoma 4
Continuous venetoclax in treatment-naive TP53 disrupted patients with chronic lymphocytic leukemia: A chronic lymphocytic leukemia campus study 3
Totale 1.949
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.335
article - articoli 8.887
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 448
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.670
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020124 0 0 0 0 24 15 7 4 19 10 26 19
2020/2021172 19 24 7 21 19 30 0 6 8 5 14 19
2021/2022219 12 50 2 10 35 4 7 12 4 14 12 57
2022/2023500 30 67 37 92 38 112 11 36 57 6 7 7
2023/2024327 11 30 49 34 25 41 20 26 9 20 49 13
2024/2025395 46 49 72 180 48 0 0 0 0 0 0 0
Totale 1.949